BIOS Fund I, LP's Form 4 filing
Lantern Pharma Inc. (LTRN) · filed Dec 1, 2023
- Accession no.
- 0001104659-23-122540
- Filed
- Dec 1, 2023, 6:01 AM ET
- Trade date
- Nov 29, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $500.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BIOS Fund I, LPCIK 0001697316 | 10% Owner |
| BIOS Fund I QP, LPCIK 0001700297 | 10% Owner |
| BIOS Fund II, LPCIK 0001714576 | 10% Owner |
| BIOS Fund II QP, LPCIK 0001716869 | 10% Owner |
| BIOS Fund II NT, LPCIK 0001728851 | 10% Owner |
| Fletcher Aaron G.L.CIK 0001789490 | 10% Owner |
| Bios Equity Partners II, LPCIK 0001813313 | 10% Owner |
| Bios Equity Partners, LPCIK 0001813314 | 10% Owner |
| BIOS Advisors GP, LLCCIK 0001813844 | 10% Owner |
| BIOS Capital Management, LPCIK 0001813845 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Common Stock | SSaleDisposed | −53,640 | $3.44 | −$184,521.6 | 217,553 | Indirect | Duplicate filing |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −91,708 | $3.44 | −$315,475.52 | 371,950 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.